Please provide your email address to receive an email when new articles are posted on . A prospective study of community-dwelling older adults demonstrated an independent relationship between silent ...
Please provide your email address to receive an email when new articles are posted on . Dhamoon and colleagues analyzed 100% de-identified inpatient, outpatient and subacute nursing Medicare data from ...
MedPage Today on MSN
Evolocumab Reduced First CV Events in Patients Without Prior MI or Stroke
NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac events (MACE) in patients with atherosclerosis or high-risk diabetes, but ...
Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...
Preventing Myocardial Infarction and Stroke With a Simplified Bundle of Cardioprotective Medications
Bundled cardioprotective medications with simplified delivery reduced the risk of hospitalization for myocardial infarction or stroke among patients at high risk. To assess the effect of promoting a ...
Can you have a stroke and not know it? Unfortunately, yes. It is a phenomenon called a silent stroke or, more formally, a silent cerebral infarction. Investigators at the University of Alabama at ...
Discover how even low intensity smoking raises long term heart risks. Keep reading to learn why quitting early matters.
Background: Rates of death from cardiovascular and cerebrovascular diseases have been steadily declining over the past few decades. Whether such declines are occurring to a similar degree for common ...
Dr Amal Mattu discusses recent studies showing that cannabis use can increase a person’s risk for cardiovascular events like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results